Clinical Trials Logo

Clinical Trial Summary

The goal of this type of randomized controlled trial, employing a blinded evaluator methodology, to verify the clinical efficacy and safety of MNK therapy. This aims to provide a reference for clinical practitioners and AAS patients in their decision-making process. Participants will randomly allocated into two groups using a random number table method, with forty patients in each group. The experimental group (Group 1) underwent MNK therapy to release the superficial fascia, while the control group (Group 2) received conventional acupuncture treatment.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06266520
Study type Interventional
Source Affiliated Dongyang Hospital of Wenzhou Medical University
Contact Sen-wei Lu, Dr.
Phone +8613989441117
Email lswlsw1121@163.com
Status Recruiting
Phase N/A
Start date January 1, 2023
Completion date June 1, 2025

See also
  Status Clinical Trial Phase
Completed NCT01874626 - Efficacy and Safety of SST 0225, a Topical Ibuprofen Cream, in the Treatment of Pain Associated With Acute Ankle Sprain Phase 3
Completed NCT01586390 - Functional Treatment for Acute Ankle Sprains: Softcast Wrap Versus MOKcast Phase 2
Completed NCT01272934 - Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Applied Four Times Daily in Subjects With Acute Ankle Sprain Phase 3